Meeting 3: The Global Breast Cancer Initiative: An Informal Dialogue on Access to Essential Breast Cancer Medicines and Technologies, Geneva, Switzerland, 18 September 2024.



The World Health Organization’s Global Breast Cancer Initiative (GBCI), established in 2021, highlights the need for early and timely diagnosis and treatment completion without abandonment to improve breast cancer survival. In this regard, WHO intends to convene an informal dialogue to discuss priorities, policies and actions that can be taken to improve access to breast cancer screening, diagnosis and treatment at population level within countries. 

Meeting 3: The Global Breast Cancer Initiative: An Informal Dialogue on Access to Essential Breast Cancer Medicines and Technologies, Geneva, Switzerland, 18 September 2024.



The World Health Organization’s Global Breast Cancer Initiative (GBCI), established in 2021, highlights the need for early and timely diagnosis and treatment completion without abandonment to improve breast cancer survival. In this regard, WHO intends to convene an informal dialogue to discuss priorities, policies and actions that can be taken to improve access to breast cancer screening, diagnosis and treatment at population level within countries. 

Meeting 3: The Global Breast Cancer Initiative: An Informal Dialogue on Access to Essential Breast Cancer Medicines and Technologies, Geneva, Switzerland, 18 September 2024.



The World Health Organization’s Global Breast Cancer Initiative (GBCI), established in 2021, highlights the need for early and timely diagnosis and treatment completion without abandonment to improve breast cancer survival. In this regard, WHO intends to convene an informal dialogue to discuss priorities, policies and actions that can be taken to improve access to breast cancer screening, diagnosis and treatment at population level within countries. 

Meeting 3: The Global Breast Cancer Initiative: An Informal Dialogue on Access to Essential Breast Cancer Medicines and Technologies, Geneva, Switzerland, 18 September 2024.



The World Health Organization’s Global Breast Cancer Initiative (GBCI), established in 2021, highlights the need for early and timely diagnosis and treatment completion without abandonment to improve breast cancer survival. In this regard, WHO intends to convene an informal dialogue to discuss priorities, policies and actions that can be taken to improve access to breast cancer screening, diagnosis and treatment at population level within countries. 

Meeting 3: The Global Breast Cancer Initiative: An Informal Dialogue on Access to Essential Breast Cancer Medicines and Technologies, Geneva, Switzerland, 18 September 2024.



The World Health Organization’s Global Breast Cancer Initiative (GBCI), established in 2021, highlights the need for early and timely diagnosis and treatment completion without abandonment to improve breast cancer survival. In this regard, WHO intends to convene an informal dialogue to discuss priorities, policies and actions that can be taken to improve access to breast cancer screening, diagnosis and treatment at population level within countries. 

Meeting 3: The Global Breast Cancer Initiative: An Informal Dialogue on Access to Essential Breast Cancer Medicines and Technologies, Geneva, Switzerland, 18 September 2024.



The World Health Organization’s Global Breast Cancer Initiative (GBCI), established in 2021, highlights the need for early and timely diagnosis and treatment completion without abandonment to improve breast cancer survival. In this regard, WHO intends to convene an informal dialogue to discuss priorities, policies and actions that can be taken to improve access to breast cancer screening, diagnosis and treatment at population level within countries. 

Meeting 3: The Global Breast Cancer Initiative: An Informal Dialogue on Access to Essential Breast Cancer Medicines and Technologies, Geneva, Switzerland, 18 September 2024.



The World Health Organization’s Global Breast Cancer Initiative (GBCI), established in 2021, highlights the need for early and timely diagnosis and treatment completion without abandonment to improve breast cancer survival. In this regard, WHO intends to convene an informal dialogue to discuss priorities, policies and actions that can be taken to improve access to breast cancer screening, diagnosis and treatment at population level within countries. 

Meeting 3: The Global Breast Cancer Initiative: An Informal Dialogue on Access to Essential Breast Cancer Medicines and Technologies, Geneva, Switzerland, 18 September 2024.



The World Health Organization’s Global Breast Cancer Initiative (GBCI), established in 2021, highlights the need for early and timely diagnosis and treatment completion without abandonment to improve breast cancer survival. In this regard, WHO intends to convene an informal dialogue to discuss priorities, policies and actions that can be taken to improve access to breast cancer screening, diagnosis and treatment at population level within countries. 

Meeting 3: The Global Breast Cancer Initiative: An Informal Dialogue on Access to Essential Breast Cancer Medicines and Technologies, Geneva, Switzerland, 18 September 2024.



The World Health Organization’s Global Breast Cancer Initiative (GBCI), established in 2021, highlights the need for early and timely diagnosis and treatment completion without abandonment to improve breast cancer survival. In this regard, WHO intends to convene an informal dialogue to discuss priorities, policies and actions that can be taken to improve access to breast cancer screening, diagnosis and treatment at population level within countries. 

Meeting 3: The Global Breast Cancer Initiative: An Informal Dialogue on Access to Essential Breast Cancer Medicines and Technologies, Geneva, Switzerland, 18 September 2024.



The World Health Organization’s Global Breast Cancer Initiative (GBCI), established in 2021, highlights the need for early and timely diagnosis and treatment completion without abandonment to improve breast cancer survival. In this regard, WHO intends to convene an informal dialogue to discuss priorities, policies and actions that can be taken to improve access to breast cancer screening, diagnosis and treatment at population level within countries. 

Meeting 3: The Global Breast Cancer Initiative: An Informal Dialogue on Access to Essential Breast Cancer Medicines and Technologies, Geneva, Switzerland, 18 September 2024.



The World Health Organization’s Global Breast Cancer Initiative (GBCI), established in 2021, highlights the need for early and timely diagnosis and treatment completion without abandonment to improve breast cancer survival. In this regard, WHO intends to convene an informal dialogue to discuss priorities, policies and actions that can be taken to improve access to breast cancer screening, diagnosis and treatment at population level within countries. 

Meeting 3: The Global Breast Cancer Initiative: An Informal Dialogue on Access to Essential Breast Cancer Medicines and Technologies, Geneva, Switzerland, 18 September 2024.



The World Health Organization’s Global Breast Cancer Initiative (GBCI), established in 2021, highlights the need for early and timely diagnosis and treatment completion without abandonment to improve breast cancer survival. In this regard, WHO intends to convene an informal dialogue to discuss priorities, policies and actions that can be taken to improve access to breast cancer screening, diagnosis and treatment at population level within countries. 

Meeting 3: The Global Breast Cancer Initiative: An Informal Dialogue on Access to Essential Breast Cancer Medicines and Technologies, Geneva, Switzerland, 18 September 2024.



The World Health Organization’s Global Breast Cancer Initiative (GBCI), established in 2021, highlights the need for early and timely diagnosis and treatment completion without abandonment to improve breast cancer survival. In this regard, WHO intends to convene an informal dialogue to discuss priorities, policies and actions that can be taken to improve access to breast cancer screening, diagnosis and treatment at population level within countries. 

Meeting 3: The Global Breast Cancer Initiative: An Informal Dialogue on Access to Essential Breast Cancer Medicines and Technologies, Geneva, Switzerland, 18 September 2024.



The World Health Organization’s Global Breast Cancer Initiative (GBCI), established in 2021, highlights the need for early and timely diagnosis and treatment completion without abandonment to improve breast cancer survival. In this regard, WHO intends to convene an informal dialogue to discuss priorities, policies and actions that can be taken to improve access to breast cancer screening, diagnosis and treatment at population level within countries. 

Meeting 3: The Global Breast Cancer Initiative: An Informal Dialogue on Access to Essential Breast Cancer Medicines and Technologies, Geneva, Switzerland, 18 September 2024.



The World Health Organization’s Global Breast Cancer Initiative (GBCI), established in 2021, highlights the need for early and timely diagnosis and treatment completion without abandonment to improve breast cancer survival. In this regard, WHO intends to convene an informal dialogue to discuss priorities, policies and actions that can be taken to improve access to breast cancer screening, diagnosis and treatment at population level within countries. 

Meeting 3: The Global Breast Cancer Initiative: An Informal Dialogue on Access to Essential Breast Cancer Medicines and Technologies, Geneva, Switzerland, 18 September 2024.



The World Health Organization’s Global Breast Cancer Initiative (GBCI), established in 2021, highlights the need for early and timely diagnosis and treatment completion without abandonment to improve breast cancer survival. In this regard, WHO intends to convene an informal dialogue to discuss priorities, policies and actions that can be taken to improve access to breast cancer screening, diagnosis and treatment at population level within countries. 

Meeting 3: The Global Breast Cancer Initiative: An Informal Dialogue on Access to Essential Breast Cancer Medicines and Technologies, Geneva, Switzerland, 18 September 2024.



The World Health Organization’s Global Breast Cancer Initiative (GBCI), established in 2021, highlights the need for early and timely diagnosis and treatment completion without abandonment to improve breast cancer survival. In this regard, WHO intends to convene an informal dialogue to discuss priorities, policies and actions that can be taken to improve access to breast cancer screening, diagnosis and treatment at population level within countries. 

Meeting 3: The Global Breast Cancer Initiative: An Informal Dialogue on Access to Essential Breast Cancer Medicines and Technologies, Geneva, Switzerland, 18 September 2024.



The World Health Organization’s Global Breast Cancer Initiative (GBCI), established in 2021, highlights the need for early and timely diagnosis and treatment completion without abandonment to improve breast cancer survival. In this regard, WHO intends to convene an informal dialogue to discuss priorities, policies and actions that can be taken to improve access to breast cancer screening, diagnosis and treatment at population level within countries. 

Meeting 3: The Global Breast Cancer Initiative: An Informal Dialogue on Access to Essential Breast Cancer Medicines and Technologies, Geneva, Switzerland, 18 September 2024.



The World Health Organization’s Global Breast Cancer Initiative (GBCI), established in 2021, highlights the need for early and timely diagnosis and treatment completion without abandonment to improve breast cancer survival. In this regard, WHO intends to convene an informal dialogue to discuss priorities, policies and actions that can be taken to improve access to breast cancer screening, diagnosis and treatment at population level within countries. 

Meeting 3: The Global Breast Cancer Initiative: An Informal Dialogue on Access to Essential Breast Cancer Medicines and Technologies, Geneva, Switzerland, 18 September 2024.



The World Health Organization’s Global Breast Cancer Initiative (GBCI), established in 2021, highlights the need for early and timely diagnosis and treatment completion without abandonment to improve breast cancer survival. In this regard, WHO intends to convene an informal dialogue to discuss priorities, policies and actions that can be taken to improve access to breast cancer screening, diagnosis and treatment at population level within countries.